MedPath

fMRI and Brainstem Evoked Response Audiometry (BERA) to Probe the Mechanism of Human Brain Auditory System in Tinnitus and Unilateral Hearing Loss

Completed
Conditions
Ringing in the ear
10019243
Registration Number
NL-OMON52331
Lead Sponsor
Keel-, Neus- en Oorheelkunde
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

To be eligible to participate in this study, the subject
- must have in the age range of 18-80 years old.
- Audiogram: [35 dB =< (pure tone average in 2, 4, and 8 kHz) =< 65] for one
ear and audiogram [(pure tone average in 2, 4, and 8 kHz) < 30] for the other
ear, if the subject is in one of the unilateral hearing loss groups.
- Audiogram: [(pure tone average in 2, 4, and 8 kHz) < 30] for both ears, if
the subject is in one of the groups with no hearing loss.
- Audiogram: [(pure tone average in 0.25 0.5, and 1 kHz) < 30] for both ears,
for all the subjects

Exclusion Criteria

- Non-conformance to any of the inclusion criteria.
- Contraindication for MRI according to the MRI checklist.
- Reported medical, neurological, or psychiatric disorders (excluding tinnitus
and hearing loss).
- Using hearing aids

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main endpoints are differences between response characteristics associated<br /><br>with unilateral hearing loss and the presence of tinnitus. These differences<br /><br>are quantified as differences between the tonotopic map of the auditory cortex<br /><br>between the subject groups. Tonotopic maps are based on the MRI acquisitions. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>A second study parameter is a difference in BERA peak amplitudes and latencies<br /><br>between the groups.</p><br>
© Copyright 2025. All Rights Reserved by MedPath